Xtx Topco LTD Infla Rx N.V. Transaction History

Xtx Topco LTD

$1.81 Billion
Q1 2025

A detailed history of Xtx Topco LTD transactions in Infla Rx N.V. stock. As of the latest transaction made, Xtx Topco LTD holds 37,528 shares of IFRX stock, worth $31,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,528

Holding current value

$31,148

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$1.02 - $2.62 $38,278 - $98,323	37,528 New	37,528 $38,000
Q1 2024 May 13, 2024	BUY	$1.47 - $2.03 $34,034 - $47,000	23,153 New	23,153 $35,000
Q3 2023 Nov 13, 2023	BUY	$2.66 - $4.33 $38,804 - $63,166	14,588 New	14,588 $43,000

Others Institutions Holding IFRX

# of Institutions

Shares Held

18.2M

Call Options Held

33.6K

Put Options Held

2.2K

Suvretta Capital Management, LLC New York, NY

6.48M
Shares

$5.38 Million
0.29% of portfolio
683 Capital Management, LLC New York, NY

2.63M
Shares

$2.18 Million
0.22% of portfolio
Eversept Partners, LP New York, NY

1.68M
Shares

$1.39 Million
0.19% of portfolio
Morgan Stanley New York, NY

1.26M
Shares

$1.05 Million
0.0% of portfolio
Silverarc Capital Management, LLC

1.16M
Shares

$964,100
0.29% of portfolio

View Full List

About InflaRx N.V.

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $36.7M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

More about IFRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account